Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors
Source: SeekingAlpha
2025-09-25 11:42:45 ET
Just over four months have passed since the publication of my last article , "Why Investors Should Watch Teva Despite Regional Risks," and during that time, the Teva Pharmaceutical Industries Limited (TEVA) share price has risen by 14%....
Read the full article on Seeking Alpha
For further details see:
Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
-0.97% G/L:
$59.9353 Last:
4,109,882 Volume:
$60.43 Open:
BMY Latest News
March 09, 2026 06:59:00 am
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
